Application Note

Highly Potent Active Pharmaceutical Ingredients Containment

Source: ILC Dover

By Scott Patterson

ILC Dover

As leaders in the field of powder containment, ILC Dover has vast experience in the delivery and testing of flexible film isolator technology for hazardous API containment applications. With the acquisition
of Solo Containment, now they can bring in extensive front-end application risk and hazard assessment skills with a methodology for SOP development. This provides an enhanced Full Lifecycle Safety Structure that ensures our customers can enjoy the highest standards of operator protection from single-use flexible film containment systems.

The Full Lifecycle Safety Structure looks at all aspects of a given pharmaceutical containment application and appraises these in eight stages, explored here.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online